Your browser doesn't support javascript.
loading
MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer.
Wang, Huaqi; Wang, Li; Zhang, Guojun; Lu, Chunya; Chu, Heying; Yang, Rui; Zhao, Guoqiang.
Afiliación
  • Wang H; Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
  • Wang L; School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China.
  • Zhang G; Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
  • Lu C; Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
  • Chu H; Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
  • Yang R; Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
  • Zhao G; School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, 450001, P.R. China.
Oncotarget ; 9(7): 7501-7512, 2018 Jan 26.
Article en En | MEDLINE | ID: mdl-29484127

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos